ANI Pharmaceuticals, Inc.ANIPNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-18.25%
↓ 422% below average
Average (39q)
5.66%
Historical baseline
Range
High:32.07%
Low:-23.82%
CAGR
+0.8%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -18.25% |
| Q2 2025 | 10.21% |
| Q1 2025 | 12.50% |
| Q4 2024 | 29.37% |
| Q3 2024 | 6.12% |
| Q2 2024 | -8.98% |
| Q1 2024 | 12.83% |
| Q4 2023 | -6.56% |
| Q3 2023 | 12.75% |
| Q2 2023 | 7.51% |
| Q1 2023 | 19.29% |
| Q4 2022 | 13.70% |
| Q3 2022 | 32.07% |
| Q2 2022 | 27.66% |
| Q1 2022 | 11.75% |
| Q4 2021 | -2.23% |
| Q3 2021 | 5.08% |
| Q2 2021 | -23.82% |
| Q1 2021 | 5.58% |
| Q4 2020 | -0.45% |
| Q3 2020 | 18.31% |
| Q2 2020 | -0.70% |
| Q1 2020 | -7.30% |
| Q4 2019 | -16.96% |
| Q3 2019 | -6.17% |
| Q2 2019 | 1.48% |
| Q1 2019 | 3.17% |
| Q4 2018 | 5.39% |
| Q3 2018 | 14.42% |
| Q2 2018 | 18.94% |
| Q1 2018 | -3.91% |
| Q4 2017 | -0.91% |
| Q3 2017 | 14.57% |
| Q2 2017 | 16.80% |
| Q1 2017 | -4.96% |
| Q4 2016 | -2.55% |
| Q3 2016 | 11.84% |
| Q2 2016 | 13.98% |
| Q1 2016 | 18.28% |
| Q4 2015 | -13.27% |